TickerFactsScreenerDevelopers

REGENERON PHARMACEUTICALS, INC. (REGN) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2009: $344.44M2010: $561.62M2011: $837.85M2012: $835.11M2013: $998.94M2014: $1.29B2015: $1.95B2016: $2.52B2017: $2.62B2018: $2.98B2019: $3.72B2020: $6.14B2021: $6.67B2022: $6.55B2023: $7.11B2024: $8.41B2025: $9.30B$9.30B
2009Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$9.30B+10.7%
2024$8.41B+18.3%
2023$7.11B+8.5%
2022$6.55B-1.7%
2021$6.67B+8.6%
2020$6.14B+65.2%
2019$3.72B+24.8%
2018$2.98B+13.6%
2017$2.62B+3.8%
2016$2.52B+29.2%
2015$1.95B+51.8%
2014$1.29B+28.9%
2013$998.94M+19.6%
2012$835.11M-0.3%
2011$837.85M+49.2%
2010$561.62M+63.1%
2009$344.44M—